Jianguo Xiao Selected Research

Carcinoma (Carcinomatosis)

1/2016	Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
1/2009	Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions.
9/2007	Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianguo Xiao Research Topics

Disease

5	Neoplasms (Cancer) 01/2016 - 09/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 05/2009
3	Carcinoma (Carcinomatosis) 01/2016 - 09/2007
1	Cutaneous Fistula 01/2021
1	Hemorrhage 01/2021
1	Intestinal Fistula 01/2021
1	Pancreatitis 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Exocrine Pancreatic Insufficiency 01/2021
1	Critical Illness (Critically Ill) 01/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2009
1	Carcinogenesis 01/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009
1	Uterine Cervical Dysplasia 09/2007
1	Mental Disorders (Mental Disorder) 08/2004

Drug/Important Bio-Agent (IBA)

2	SaponinsIBA 04/2014 - 08/2012
2	formosanin CIBA 04/2014 - 08/2012
2	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2012 - 09/2007
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2012 - 09/2007
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014
1	polyphyllin DIBA 05/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	Sirolimus (Rapamycin)FDA Link 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2009
1	TOR Serine-Threonine KinasesIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 09/2007

Therapy/Procedure

2	Therapeutics 05/2009 - 01/2009
1	Minimally Invasive Surgical Procedures 01/2021
1	Length of Stay 01/2021
1	Intravenous Injections 01/2019
1	Enteral Nutrition (Feeding, Tube) 01/2019
1	Nutritional Support (Artificial Feeding) 01/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Aftercare (After-Treatment) 08/2004